G-CSF use in patients receiving first-line chemotherapy for non-Hodgkin’s lymphoma (NHL) and granulocyte-colony stimulating factors (G-CSF) as observed in clinical practice in Italy
出版年份 2016 全文链接
标题
G-CSF use in patients receiving first-line chemotherapy for non-Hodgkin’s lymphoma (NHL) and granulocyte-colony stimulating factors (G-CSF) as observed in clinical practice in Italy
作者
关键词
Granulocyte-colonystimulating factor, Febrile neutropenia, Chemotherapy, Non-Hodgkin’s lymphoma, Observational study, Clinical practice
出版物
MEDICAL ONCOLOGY
Volume 33, Issue 12, Pages -
出版商
Springer Nature
发表日期
2016-11-07
DOI
10.1007/s12032-016-0850-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Impact of Chemotherapy Dose Intensity on Cancer Patient Outcomes
- (2017) Gary H. Lyman Journal of the National Comprehensive Cancer Network
- Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor
- (2015) Tara Arvedson et al. BIODRUGS
- Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2015) Thomas J. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
- (2015) Li Wang et al. SUPPORTIVE CARE IN CANCER
- Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis
- (2014) Derek Weycker et al. BMC HEALTH SERVICES RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia
- (2014) Sol Cortés de Miguel et al. SUPPORTIVE CARE IN CANCER
- Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review
- (2014) Alena M. Pfeil et al. SUPPORTIVE CARE IN CANCER
- The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials
- (2013) G. H. Lyman et al. ANNALS OF ONCOLOGY
- A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice
- (2013) S. Barni et al. MEDICAL ONCOLOGY
- A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia
- (2013) Brian Dulisse et al. JOURNAL OF MEDICAL ECONOMICS
- ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
- (2012) M. Ghielmini et al. ANNALS OF ONCOLOGY
- Impact of Age Group on Febrile Neutropenia Risk Assessment and Management in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP Regimens
- (2012) Pieternella Lugtenburg et al. Clinical Lymphoma Myeloma & Leukemia
- Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice
- (2012) Hans E. Johnsen et al. LEUKEMIA & LYMPHOMA
- The need for improved neutropenia risk assessment in DLBCL patients receiving R-CHOP-21: Findings from clinical practice
- (2012) Antonio Salar et al. LEUKEMIA RESEARCH
- Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma
- (2011) Ruth Pettengell et al. SUPPORTIVE CARE IN CANCER
- Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications
- (2010) J. Crawford et al. ANNALS OF ONCOLOGY
- How I treat elderly patients with diffuse large B-cell lymphoma
- (2010) M. Pfreundschuh BLOOD
- Risk of mortality in patients with cancer who experience febrile neutropenia
- (2010) Gary H. Lyman et al. CANCER
- Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma
- (2010) Hans Wildiers et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
- (2010) M.S. Aapro et al. EUROPEAN JOURNAL OF CANCER
- Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial
- (2009) S. Luminari et al. ANNALS OF ONCOLOGY
- Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy
- (2008) R. Pettengell et al. ANNALS OF HEMATOLOGY
- Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
- (2008) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study
- (2008) Ruth Pettengell et al. SUPPORTIVE CARE IN CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now